Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage function.Published in:Inflammation Research, 2024, v. 73, n. 3, p. 345, doi. 10.1007/s00011-023-01840-xBy:Liang, Qing-hua;Li, Qiu-rong;Chen, Zhong;Lv, Li-juan;Lin, Yu;Jiang, Hong-lv;Wang, Ke-xin;Xiao, Ming-yue;Kang, Nai-xin;Tu, Peng-fei;Ji, Shi-liang;Deng, Ke-jun;Gao, Hong-wei;Zhang, Li;Li, Kun;Ge, Fei;Xu, Guo-qiang;Yang, Shi-lin;Liu, Yan-li;Xu, Qiong-mingPublication type:Article